Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Histone Deacetylase Inhibitors and Phenotypical Transformation of Cancer Cells
Anna Wawruszak, Joanna Kałafut, Estera Okoń, et al.
Cancers (2019) Vol. 11, Iss. 2, pp. 148-148
Open Access | Times Cited: 90

Showing 1-25 of 90 citing articles:

Stem Cell Plasticity and Dormancy in the Development of Cancer Therapy Resistance
Maria Laura De Angelis, Federica Francescangeli, Filippo La Torre, et al.
Frontiers in Oncology (2019) Vol. 9
Open Access | Times Cited: 180
Effects of Intestinal Microbial–Elaborated Butyrate on Oncogenic Signaling Pathways
Jiezhong Chen, Kong‐Nan Zhao, Luis Vitetta
Nutrients (2019) Vol. 11, Iss. 5, pp. 1026-1026
Open Access | Times Cited: 148
Hypoxia-Induced Cancer Cell Responses Driving Radioresistance of Hypoxic Tumors: Approaches to Targeting and Radiosensitizing
Alexander E. Kabakov, A. O. Yakimova
Cancers (2021) Vol. 13, Iss. 5, pp. 1102-1102
Open Access | Times Cited: 105
Targeting histone deacetylases for cancer therapy: Trends and challenges
Liang Tao, Fengli Wang, Reham M. Elhassan, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 6, pp. 2425-2463
Open Access | Times Cited: 83
Advances in targeting histone deacetylase for treatment of solid tumors
Mu-Qi Shi, Ying Xu, Xin Fu, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 25
Butyrate Suppresses Glucose Metabolism of Colorectal Cancer Cells via GPR109a-AKT Signaling Pathway and Enhances Chemotherapy
Hongwei Geng, Fengyi Yin, Zhifa Zhang, et al.
Frontiers in Molecular Biosciences (2021) Vol. 8
Open Access | Times Cited: 83
Thiadiazole derivatives as anticancer agents
Monika Szeliga
Pharmacological Reports (2020) Vol. 72, Iss. 5, pp. 1079-1100
Open Access | Times Cited: 75
Vorinostat (SAHA) and Breast Cancer: An Overview
Anna Wawruszak, Lidia Borkiewicz, Estera Okoń, et al.
Cancers (2021) Vol. 13, Iss. 18, pp. 4700-4700
Open Access | Times Cited: 74
Effects of statins on brain tumors: a review
Amir R. Afshari, Hamid Mollazadeh, Neil C. Henney, et al.
Seminars in Cancer Biology (2020) Vol. 73, pp. 116-133
Open Access | Times Cited: 70
The Impact of the Microbiome on Resistance to Cancer Treatment with Chemotherapeutic Agents and Immunotherapy
Aneta Sevcikova, Nikola Izoldova, Viola Stevurkova, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 1, pp. 488-488
Open Access | Times Cited: 63
A prismatic view of the epigenetic-metabolic regulatory axis in breast cancer therapy resistance
Chandrima Das, Apoorva Bhattacharya, Swagata Adhikari, et al.
Oncogene (2024) Vol. 43, Iss. 23, pp. 1727-1741
Open Access | Times Cited: 10
Inhibition of BET Proteins and Histone Deacetylase (HDACs): Crossing Roads in Cancer Therapy
Gloria Manzotti, Alessia Ciarrocchi, Valentina Sancisi
Cancers (2019) Vol. 11, Iss. 3, pp. 304-304
Open Access | Times Cited: 74
PROTAC: A promising technology for cancer treatment
Xin Zhou, Ru Dong, Jinyang Zhang, et al.
European Journal of Medicinal Chemistry (2020) Vol. 203, pp. 112539-112539
Closed Access | Times Cited: 66
H3K18Ac as a Marker of Cancer Progression and Potential Target of Anti-Cancer Therapy
Marta Hałasa, Anna Wawruszak, Alicja Przybyszewska-Podstawka, et al.
Cells (2019) Vol. 8, Iss. 5, pp. 485-485
Open Access | Times Cited: 65
Apoptosis Induction byHistone Deacetylase Inhibitors in Cancer Cells: Role of Ku70
Ping Gong, Yuetong Wang, Yongkui Jing
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 7, pp. 1601-1601
Open Access | Times Cited: 56
Valproic Acid and Breast Cancer: State of the Art in 2021
Anna Wawruszak, Marta Hałasa, Estera Okoń, et al.
Cancers (2021) Vol. 13, Iss. 14, pp. 3409-3409
Open Access | Times Cited: 52
Characterization of Histone Deacetylase Mechanisms in Cancer Development
Rihan Hai, Liuer He, Guang Shu, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 47
Targeting Histone Deacetylases: Opportunities for Cancer Treatment and Chemoprevention
Dušan Ružić, Nemanja Djoković, Tatjana Srdić‐Rajić, et al.
Pharmaceutics (2022) Vol. 14, Iss. 1, pp. 209-209
Open Access | Times Cited: 37
Advances in dual-targeting inhibitors of HDAC6 for cancer treatment
Zhicheng Gu, Shuxian Lin, Junhui Yu, et al.
European Journal of Medicinal Chemistry (2024) Vol. 275, pp. 116571-116571
Closed Access | Times Cited: 6
Discovery of selective HDAC/BRD4 dual inhibitors as epigenetic probes
Jingjing Chen, Yalei Li, Jie Zhang, et al.
European Journal of Medicinal Chemistry (2020) Vol. 209, pp. 112868-112868
Closed Access | Times Cited: 49
Up-regulated circBACH2 contributes to cell proliferation, invasion, and migration of triple-negative breast cancer
Xinxing Wang, Bingjian Xue, Yujie Zhang, et al.
Cell Death and Disease (2021) Vol. 12, Iss. 5
Open Access | Times Cited: 36
Differential molecular mechanistic behavior of HDACs in cancer progression
Tashvinder Singh, Prabhsimran Kaur, Paramdeep Singh, et al.
Medical Oncology (2022) Vol. 39, Iss. 11
Closed Access | Times Cited: 25
Mechanism-based approaches of 1,3,4 thiadiazole scaffolds as potent enzyme inhibitors for cytotoxicity and antiviral activity
Davinder Kumar, Harsh Kumar, Virender Kumar, et al.
Medicine in Drug Discovery (2022) Vol. 17, pp. 100150-100150
Open Access | Times Cited: 25
Drug Resistance: An Incessant Fight against Evolutionary Strategies of Survival
Francisco Ramos‐Martín, Nicola D’Amelio
Microbiology Research (2023) Vol. 14, Iss. 2, pp. 507-542
Open Access | Times Cited: 14
The Emerging Roles of Heterochromatin in Cell Migration
Gabi Gerlitz
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 37
Page 1 - Next Page

Scroll to top